Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples